Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Research Frontiers (REFR) Asset Writedowns and Impairment (2017 - 2025)

Research Frontiers (REFR) has disclosed Asset Writedowns and Impairment for 6 consecutive years, with $30000.0 as the latest value for Q4 2025.

  • Quarterly Asset Writedowns and Impairment changed N/A to $30000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $30000.0 through Dec 2025, down 70.0% year-over-year, with the annual reading at $154253.0 for FY2025, 516.99% up from the prior year.
  • Asset Writedowns and Impairment hit $30000.0 in Q4 2025 for Research Frontiers, down from $100000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $100000.0 in Q3 2023 to a low of -$10000.0 in Q4 2022.
  • Historically, Asset Writedowns and Impairment has averaged $22000.0 across 3 years, with a median of -$5000.0 in 2022.
  • Biggest YoY gain for Asset Writedowns and Impairment was 2100.0% in 2023; the steepest drop was 2100.0% in 2023.
  • Year by year, Asset Writedowns and Impairment stood at -$10000.0 in 2022, then soared by 1100.0% to $100000.0 in 2023, then crashed by 70.0% to $30000.0 in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for REFR at $30000.0 in Q4 2025, $100000.0 in Q3 2023, and -$5000.0 in Q1 2023.